BIOSPECIFICS TECHNOLOGIES CORP Contracts & Agreements

Agreement and Plan of Merger, dated as of October 19, 2020, by and among BioSpecifics Technologies Corp., Endo International plc, and Beta Acquisition Corp (Filed With SEC on October 19, 2020)

Amendment No. 1 to Rights Agreement, dated as of October 19, 2020, to the Rights Agreement, dated as of April 10, 2020, by and between BioSpecifics Technologies Corp. and... (Filed With SEC on October 19, 2020)

At-The-Market Equity Offering Sales Agreement, dated August 31, 2020, among the Company, Stifel, Nicolaus & Company, Incorporated and Oppenheimer & Co. Inc (Filed With SEC on August 31, 2020)

Amendment to Letter Agreement, dated June 4, 2020, by and between the Company and Patrick Hutchison (Filed With SEC on August 10, 2020)

Employment Agreement, dated June 19, 2020, by and between the Company and Alex Monteith (Filed With SEC on August 10, 2020)

Separation of Employment Agreement and General Release, dated March 31, 2020, by and between the Company and Patrick Caldwell (Filed With SEC on May 11, 2020)

Separation of Employment Agreement and General Release, dated April 6, 2020, by and between the Company and J. Kevin Buchi (Filed With SEC on May 11, 2020)

Letter Agreement, dated April 6, 2020, by and between the Company and Joseph Truitt (Filed With SEC on May 11, 2020)

Employment Agreement, dated May 7, 2020, by and between the Company and Joseph Truitt (Filed With SEC on May 11, 2020)

Confidentiality and Inventions Assignment Agreement, dated April 1, 2020, by and between the Company and Joseph Truitt (Filed With SEC on May 11, 2020)

Rights Agreement, dated as of April 10, 2020, by and between BioSpecifics Technologies Corp. and Worldwide Stock Transfer, LLC, as rights agent (Filed With SEC on April 10, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on March 16, 2020)

BioSpecifics Technologies 2019 Omnibus Incentive Compensation Plan J. Kevin Buchi Performance Stock Unit Award Agreement (Filed With SEC on March 16, 2020)

Employment Letter Agreement, dated January 6, 2020, by and between the Company and Patrick Hutchison (Filed With SEC on March 16, 2020)

Lease Agreement, dated December 16, 2019, by and between the Company and 2 Righter LLC (Filed With SEC on March 16, 2020)

Employment Agreement by and between BioSpecifics Technology Corp., Advance Biofactures Corporation, and J. Kevin Buchi (Filed With SEC on November 12, 2019)

Form of Non-Qualified Stock Option Award Agreement (Filed With SEC on November 12, 2019)

Amended Agreement of Lease, dated as of November 6, 2019, among the Company, ABC-NY and 35 Wilbur Street Associates (Filed With SEC on November 12, 2019)

Form of Director Restricted Stock Unit Award Agreement (Filed With SEC on August 9, 2019)

Restricted Stock Unit Award Agreement for P. Caldwell (Filed With SEC on August 9, 2019)

Amendment No. 4 to Rights Agreement, dated May 27, 2016, by and between the Company and Worldwide Stock Transfer, LLC (as successor in interest to OTC Corporate Transfer Service... (Filed With SEC on April 2, 2019)

Amendment No. 5 to Rights Agreement, dated May 11, 2018, by and between the Company and Worldwide Stock Transfer, LLC (as successor in interest to OTC Corporate Transfer Service... (Filed With SEC on April 2, 2019)

Offer Letter, dated November 15, 2018, by and between and Dr. Ronald E. Law (Filed With SEC on April 2, 2019)

Amendment to Offer Letter, dated March 4, 2019, by and between and Dr. Ronald E. Law (Filed With SEC on April 2, 2019)

Second Amendment to Offer Letter, dated April 1, 2019, by and between and Dr. Ronald E. Law (Filed With SEC on April 2, 2019)

Confidentiality and Inventions Assignment Agreement, dated November 16, 2018, by and between and Dr. Ronald E. Law (Filed With SEC on April 2, 2019)

Consulting Agreement, dated April 1, 2019, by and between the Company and Patrick M. Caldwell (Filed With SEC on April 2, 2019)

Amended and Restated Indemnification Agreement, dated September 12, 2012, by and between the Company and Patrick M. Caldwell (Filed With SEC on April 2, 2019)

Second Amendment to Second Amended and Restated Development License Agreement, dated February 26, 2019, by and between the Company and Endo Global Ventures (Filed With SEC on February 28, 2019)

Amended Agreement of Lease, dated as of August 14, 2018, among the Company, ABC-NY and 35 Wilbur Street Associates (Filed With SEC on November 9, 2018)

Amended Agreement of Lease, dated as of November 6, 2017, among the Company, ABC-NY and 35 Wilbur Street Associates (Filed With SEC on November 9, 2017)

Amended Agreement of Lease, dated as of November 1, 2016, among the Company, ABC-NY and 35 Wilbur Street Associates (Filed With SEC on November 9, 2016)

BIOSPECIFICS TECHNOLOGIES CORP. Non-Employee Director Change of Control Agreement (Filed With SEC on March 14, 2016)

First Amendment to Second Amended and Restated Development and License Agreement, by and between the Company and Endo Global Ventures, entered into as of February 1, 2016, with an... (Filed With SEC on February 5, 2016)

Amended Agreement of Lease, dated as of August 14, 2015, among the Company, ABC-NY and 35 Wilbur Street Associates (Filed With SEC on November 9, 2015)

Consulting Agreement, dated as of August 4, 2014, by and between BioSpecifics Technologies Corp. and Mr. Henry Morgan (Filed With SEC on August 5, 2014)

Amendment No.3 Rights Agreement, dated as of March 5, 2014 (Filed With SEC on March 7, 2014)

Agreement of Lease, dated as of November 21, 2013, between the Company, ABC-NY and 35 Wilbur Street Associates, LLC (Filed With SEC on March 7, 2014)

Lease Termination Agreement, dated as of November 21, 2013, between the Company, ABC-NY and Wilbur St. Corp (Filed With SEC on March 7, 2014)

Change of Control Agreement, dated as of September 17, 2013, between the Company and George Gould (Filed With SEC on March 7, 2014)

Cellulite License Agreement dated August 23, 2007 between the Company and the Research Foundation (Filed With SEC on March 15, 2013)

License Agreement dated March 27, 2010 between the Company and Zachary Gerut, M.D (Filed With SEC on March 15, 2013)

Amendment dated March 31, 2012 (Filed With SEC on August 13, 2012)

Consulting Agreement, effective as of July 1, 2012, among BioSpecifics Technologies Corp., Dr. Matthew Geller and Geller Biopharm, Inc (Filed With SEC on April 27, 2012)

Amendment dated March 31, 2012 (Filed With SEC on April 5, 2012)

Second Amended and Restated Development and License Agreement, dated as of August 31, 2011, by and between BioSpecifics Technologies Corp. and Auxilium Pharmaceuticals, Inc (Filed With SEC on September 1, 2011)

Settlement Agreement, dated as of August 31, 2011, by and between BioSpecifics Technologies Corp. and Auxilium Pharmaceuticals, Inc (Filed With SEC on September 1, 2011)

Second Amendment, dated as of February 3, 2011, to the Rights Agreement, dated as of May 14, 2002, between the Company and OTC Corporate Transfer Service Company, as rights agent (Filed With SEC on February 4, 2011)

Lease Modification Agreement dated June 22, 2009 and effective June 24, 2009 (Filed With SEC on June 29, 2009)

Change of Control Agreement, dated October 1, 2008 between the Company and Dr. Matthew Geller (Filed With SEC on March 31, 2009)

Amended and Restated Agreement dated December 11, 2008 and effective December 17, 2008 (Filed With SEC on December 19, 2008)

Agreement dated August 27, 2008 (Filed With SEC on September 5, 2008)

Executive Employment Agreement, between Thomas L. Wegman and BioSpecifics (Filed With SEC on August 8, 2008)

Form of Director Change of Control Agreement (Filed With SEC on June 22, 2007)

Wegman Change of Control Agreement, between Thomas L. Wegman and BioSpecifics Technologies Corp., dated June 18, 2007 (Filed With SEC on June 22, 2007)

Amendment to the Asset Purchase Agreement (Filed With SEC on January 12, 2007)

Dupuytrens Disease License Agreement, dated November 21, 2006, between BioSpecifics Technologies Corp., and the Research Foundation of the State University of New York for and on... (Filed With SEC on November 28, 2006)

Frozen Shoulder License Agreement, dated November 21, 2006, between BioSpecifics Technologies Corp., and the Research Foundation of the State University of New York for and on... (Filed With SEC on November 28, 2006)

Form of Stock Option Notice and Letter Agreement under the 2001 Stock Option Plan (Filed With SEC on September 19, 2006)

Form of Stock Option Notice and Letter Agreement under the 2001 Stock Option Plan (Filed With SEC on September 12, 2006)

Category

Industry

Companies

Contracts

BIOSPECIFICS TECHNOLOGIES CORP Contracts & Agreements